Novel R-roscovitine NO-donor hybrid compounds as potential pro-resolution of inflammation agents
…, M Bertinaria, B Rolando, R Fruttero, CD Lucas…
Index: Montanaro, Gabriele; Bertinaria, Massimo; Rolando, Barbara; Fruttero, Roberta; Lucas, Christopher D.; Dorward, David A.; Rossi, Adriano G.; Megson, Ian L.; Gasco, Alberto Bioorganic and Medicinal Chemistry, 2013 , vol. 21, # 7 p. 2107 - 2116
Full Text: HTML
Citation Number: 6
Abstract
Neutrophils play a pivotal role in the pathophysiology of multiple human inflammatory diseases. Novel pharmacological strategies which drive neutrophils to undergo programmed cell death (apoptosis) have been shown to facilitate the resolution of inflammation. Both the cyclin-dependent kinase inhibitor (CDKi) R-roscovitine and nitric oxide (NO) have been shown to enhance apoptosis of neutrophils and possess pro- ...
Related Articles:
[Tak-Tak, Lotfi; Barbault, Florent; Maurel, Franois; Busca, Patricia; Le Merrer, Yves European Journal of Medicinal Chemistry, 2011 , vol. 46, # 4 p. 1254 - 1262]
[Journal of Medicinal Chemistry, , vol. 46, # 23 p. 4974 - 4987]
[Journal of Medicinal Chemistry, , vol. 46, # 23 p. 4974 - 4987]
[Organic and Biomolecular Chemistry, , vol. 2, # 5 p. 665 - 670]
[Organic and Biomolecular Chemistry, , vol. 2, # 5 p. 665 - 670]